aluates Reports

$ 0.0

Automative

Global Peptide Receptor Radionuclide Therapy (PRRT) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-0E14476

Global Peptide Receptor Radionuclide Therapy PRRT Market Research Report 2023

BUY CHAPTERS

Global Peptide Receptor Radionuclide Therapy (PRRT) Market Research Report 2025

Code: QYRE-Auto-0E14476

Report

September 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Bayer

Lantheus

Aurobindo Pharma

Mundipharma

Curium Pharmaceuticals

Peptide Receptor Radionuclide Therapy (PRRT) Market Size

The global market for Peptide Receptor Radionuclide Therapy (PRRT) was valued at US$ 1976 million in the year 2024 and is projected to reach a revised size of US$ 5994 million by 2031, growing at a CAGR of 17.4% during the forecast period.

Peptide Receptor Radionuclide Therapy (PRRT) Market

Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Peptide Receptor Radionuclide Therapy (PRRT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Receptor Radionuclide Therapy (PRRT).

The Peptide Receptor Radionuclide Therapy (PRRT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Receptor Radionuclide Therapy (PRRT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Receptor Radionuclide Therapy (PRRT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide Receptor Radionuclide Therapy (PRRT) Market Report

Report Metric	Details
Report Name	Peptide Receptor Radionuclide Therapy (PRRT) Market
Accounted market size in year	US$ 1976 million
Forecasted market size in 2031	US$ 5994 million
CAGR	17.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gastroenteropancreatic Neuroendocrine Tumor Foregut Neuroendocrine Tumor Midgut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, Curium Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Receptor Radionuclide Therapy (PRRT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Receptor Radionuclide Therapy (PRRT) Market growing?

Ans: The Peptide Receptor Radionuclide Therapy (PRRT) Market witnessing a CAGR of 17.4% during the forecast period 2025-2031.

What is the Peptide Receptor Radionuclide Therapy (PRRT) Market size in 2031?

Ans: The Peptide Receptor Radionuclide Therapy (PRRT) Market size in 2031 will be US$ 5994 million.

Who are the main players in the Peptide Receptor Radionuclide Therapy (PRRT) Market report?

Ans: The main players in the Peptide Receptor Radionuclide Therapy (PRRT) Market are Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, Curium Pharmaceuticals

What are the Application segmentation covered in the Peptide Receptor Radionuclide Therapy (PRRT) Market report?

Ans: The Applications covered in the Peptide Receptor Radionuclide Therapy (PRRT) Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Peptide Receptor Radionuclide Therapy (PRRT) Market report?

Ans: The Types covered in the Peptide Receptor Radionuclide Therapy (PRRT) Market report are Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor, Midgut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor

Recommended Reports

Radiopharmaceuticals & Radionuclide

Radiation Therapy Devices

Cancer Therapy & Targeted

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gastroenteropancreatic Neuroendocrine Tumor

1.2.3 Foregut Neuroendocrine Tumor

1.2.4 Midgut Neuroendocrine Tumor

1.2.5 Hindgut Neuroendocrine Tumor

1.3 Market by Application

1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2020-2031)

2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Region

2.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Region (2020-2025)

2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Region (2026-2031)

2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Dynamics

2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends

2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers

2.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges

2.3.4 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue

3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2020-2025)

3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2020-2025)

3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue

3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio

3.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2024

3.5 Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT) Head office and Area Served

3.6 Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT), Product and Application

3.7 Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Type

4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2020-2025)

4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2026-2031)

5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application

5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Application (2020-2025)

5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)

6.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)

6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)

7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)

7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)

8.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)

9.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)

9.4 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)

10.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.1.4 Bayer Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.2.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Lantheus

11.3.1 Lantheus Company Details

11.3.2 Lantheus Business Overview

11.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.3.4 Lantheus Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.3.5 Lantheus Recent Development

11.4 Aurobindo Pharma

11.4.1 Aurobindo Pharma Company Details

11.4.2 Aurobindo Pharma Business Overview

11.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.4.4 Aurobindo Pharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.4.5 Aurobindo Pharma Recent Development

11.5 Mundipharma

11.5.1 Mundipharma Company Details

11.5.2 Mundipharma Business Overview

11.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.5.4 Mundipharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.5.5 Mundipharma Recent Development

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Details

11.6.2 Curium Pharmaceuticals Business Overview

11.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Introduction

11.6.4 Curium Pharmaceuticals Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

11.6.5 Curium Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Bayer

Lantheus

Aurobindo Pharma

Mundipharma

Curium Pharmaceuticals

List of Tables

Table 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gastroenteropancreatic Neuroendocrine Tumor

Table 3. Key Players of Foregut Neuroendocrine Tumor

Table 4. Key Players of Midgut Neuroendocrine Tumor

Table 5. Key Players of Hindgut Neuroendocrine Tumor

Table 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2020-2025)

Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2026-2031)

Table 12. Peptide Receptor Radionuclide Therapy (PRRT) Market Trends

Table 13. Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers

Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges

Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints

Table 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players (2020-2025)

Table 18. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2024)

Table 19. Ranking of Global Top Peptide Receptor Radionuclide Therapy (PRRT) Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT), Headquarters and Area Served

Table 22. Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT), Product and Application

Table 23. Global Key Players of Peptide Receptor Radionuclide Therapy (PRRT), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2020-2025)

Table 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2026-2031)

Table 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2020-2025)

Table 31. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2026-2031)

Table 33. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bayer Company Details

Table 49. Bayer Business Overview

Table 50. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 51. Bayer Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 52. Bayer Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 56. Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Lantheus Company Details

Table 59. Lantheus Business Overview

Table 60. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 61. Lantheus Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 62. Lantheus Recent Development

Table 63. Aurobindo Pharma Company Details

Table 64. Aurobindo Pharma Business Overview

Table 65. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 66. Aurobindo Pharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 67. Aurobindo Pharma Recent Development

Table 68. Mundipharma Company Details

Table 69. Mundipharma Business Overview

Table 70. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 71. Mundipharma Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 72. Mundipharma Recent Development

Table 73. Curium Pharmaceuticals Company Details

Table 74. Curium Pharmaceuticals Business Overview

Table 75. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product

Table 76. Curium Pharmaceuticals Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025) & (US$ Million)

Table 77. Curium Pharmaceuticals Recent Development

Table 78. Research Programs/Design for This Report

Table 79. Key Data Information from Secondary Sources

Table 80. Key Data Information from Primary Sources

Table 81. Authors List of This Report

List of Figures

Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Picture

Figure 2. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type: 2024 VS 2031

Figure 4. Gastroenteropancreatic Neuroendocrine Tumor Features

Figure 5. Foregut Neuroendocrine Tumor Features

Figure 6. Midgut Neuroendocrine Tumor Features

Figure 7. Hindgut Neuroendocrine Tumor Features

Figure 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered

Figure 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region: 2024 VS 2031

Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players in 2024

Figure 18. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2024

Figure 20. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2020-2031)

Figure 22. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2020-2031)

Figure 26. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2020-2031)

Figure 34. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2020-2031)

Figure 42. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2020-2031)

Figure 46. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bayer Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 51. Lantheus Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 52. Aurobindo Pharma Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 53. Mundipharma Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 54. Curium Pharmaceuticals Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Radioisotope Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Peptide Therapy Market Research Report 2025

Global Radioimmunotherapy Market Research Report 2025

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Neuroendocrine Tumors NETs Treatment Market Insights Forecast to 2030

Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plasma Therapy Market Insights Forecast to 2030

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Radiotherapy Drug Market Research Report 2024

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024

Global Systemic Radiotherapy Market Research Report 2024

Global RDC Radionuclide Drug Conjugate Services Market Research Report 2024

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroendocrine Tumor Treatment Market Insights Forecast to 2030

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Platelet rich Plasma Therapy Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions